Human cytomegalovirus modulates expression of noncanonical Wnt receptor ROR2 to alter trophoblast migration

Journal of Virology

Volumn 90, Issue 2, 2016, Pages 1108-1115

  van Zuylen, Wendy J ^a,b   Ford, Caroline E ^c   Wong, Diana D Y ^a,b   Rawlinson, William D ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FRIZZLED PROTEIN; LYMPHOID ENHANCER FACTOR; PROTEIN ROR2; SMALL INTERFERING RNA; T CELL SPECIFIC FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT5A PROTEIN; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; ROR2 PROTEIN, HUMAN;

ARTICLE; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOPATHOGENIC EFFECT; DOWN REGULATION; EMBRYO; FETUS DISEASE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; LUCIFERASE ASSAY; MTT ASSAY; NONHUMAN; PLACENTA DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLAST; VIRUS CELL INTERACTION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; CELL LINE; CELL MOTION; CYTOMEGALOVIRUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY;

BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CYTOMEGALOVIRUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; TROPHOBLASTS;

EID: 84954092066     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02588-15     Document Type: Article

References (56)

1. Dollard SC, Grosse SD, Ross DS. 2007. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17:355-363. http://dx.doi.org/10.1002/rmv.544.
2. Kenneson A, Cannon MJ. 2007. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253-276. http://dx.doi.org/10.1002/rmv.535.
3. McMullan BJ, Palasanthiran P, Jones CA, Hall BM, Robertson PW, Howard J, Rawlinson WD. 2011. Congenital cytomegalovirus-time to diagnosis, management and clinical sequelae in Australia: opportunities for earlier identification. Med J Aust 194:625-629.
4. Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, Rawlinson WD. 2005. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 43:4713-4718. http://dx.doi.org/10.1128/JCM.43.9.4713-4718.2005.
5. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. 1992. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11:93-99. http://dx.doi.org/10.1097/00006454-199202000-00007.
6. Munro SC, Trincado D, Hall B, Rawlinson WD. 2005. Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. J Paediatr Child Health 41:449-452. http://dx.doi.org/10.1111/j.1440-1754.2005.00665.x.
7. van Zuylen W, Hamilton S, Naing Z, Hall B, Shand A, Rawlinson W. 2014. Congenital cytomegalovirus infection: clinical presentation, epidemiology, diagnosis and prevention. Obstet Med 7:140-146. http://dx.doi.org/10.1177/1753495X14552719.
8. Iwasenko JM, Howard J, Arbuckle S, Graf N, Hall B, Craig ME, Rawlinson WD. 2011. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis 203:1526-1533. http://dx.doi.org/10.1093/infdis/jir121.
9. Pereira L, Petitt M, Fong A, Tsuge M, Tabata T, Fang-Hoover J, Maidji E, Zydek M, Zhou Y, Inoue N, Loghavi S, Pepkowitz S, Kauvar LM, Ogunyemi D. 2014. Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection. J Infect Dis 209:1573-1584. http://dx.doi.org/10.1093/infdis/jiu019.
10. Williams EJ, Embleton ND, Clark JE, Bythell M, Ward Platt MP, Berrington JE. 2013. Viral infections: contributions to late fetal death, stillbirth, and infant death. J Pediatr 163:424-428. http://dx.doi.org/10.1016/j.jpeds.2013.02.004.
11. Lorenzoni F, Lunardi S, Liumbruno A, Ferri G, Madrigali V, Fiorentini E, Forli F, Berrettini S, Boldrini A, Ghirri P. 2014. Neonatal screening for congenital cytomegalovirus infection in preterm and small for gestational age infants. J Matern Fetal Neonatal Med 27:1589-1593. http://dx.doi.org/10.3109/14767058.2013.871253.
12. Xie F, Hu Y, Magee LA, Money DM, Patrick DM, Krajden M, Thomas E, von Dadelszen P. 2010. An association between cytomegalovirus infection and pre-eclampsia: a case-control study and data synthesis. Acta Obstet Gynecol Scand 89:1162-1167. http://dx.doi.org/10.3109/00016349.2010.499449.
13. Gabrielli L, Bonasoni MP, Lazzarotto T, Lega S, Santini D, Foschini MP, Guerra B, Baccolini F, Piccirilli G, Chiereghin A, Petrisli E, Gardini G, Lanari M, Landini MP. 2009. Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 46(Suppl 4):S16-S21. http://dx.doi.org/10.1016/j.jcv.2009.09.026.
14. Scott GM, Chow SS, Craig ME, Pang CN, Hall B, Wilkins MR, Jones CA, Lloyd AR, Rawlinson WD. 2012. Cytomegalovirus infection during pregnancy with maternofetal transmission induces a proinflammatory cytokine bias in placenta and amniotic fluid. J Infect Dis 205:1305-1310. http://dx.doi.org/10.1093/infdis/jis186.
15. Hamilton ST, Scott G, Naing Z, Iwasenko J, Hall B, Graf N, Arbuckle S, Craig ME, Rawlinson WD. 2012. Human cytomegalovirus-induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One 7:e52899. http://dx.doi.org/10.1371/journal.pone.0052899.
16. Maidji E, Nigro G, Tabata T, McDonagh S, Nozawa N, Shiboski S, Muci S, Anceschi MM, Aziz N, Adler SP, Pereira L. 2010. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 177:1298-1310. http://dx.doi.org/10.2353/ajpath.2010.091210.
17. Hamilton ST, van Zuylen W, Shand A, Scott GM, Naing Z, Hall B, Craig ME, Rawlinson WD. 2014. Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev Med Virol 24:420-433. http://dx.doi.org/10.1002/rmv.1814.
18. Garcia AG, Fonseca EF, Marques RL, Lobato YY. 1989. Placental morphology in cytomegalovirus infection. Placenta 10:1-18. http://dx.doi.org/10.1016/0143-4004(89)90002-7.
19. Benirschke K, Kaufmann P. 2013. Pathology of the human placenta. Springer, New York, NY.
20. Rauwel B, Mariame B, Martin H, Nielsen R, Allart S, Pipy B, Mandrup S, Devignes MD, Evain-Brion D, Fournier T, Davrinche C. 2010. Activation of peroxisome proliferator-activated receptor gamma by human cytomegalovirus for de novo replication impairs migration and invasiveness of cytotrophoblasts from early placentas. J Virol 84:2946-2954. http://dx.doi.org/10.1128/JVI.01779-09.
21. Tabata T, McDonagh S, Kawakatsu H, Pereira L. 2007. Cytotrophoblasts infected with a pathogenic human cytomegalovirus strain dysregulate cell-matrix and cell-cell adhesion molecules: a quantitative analysis. Placenta 28:527-537. http://dx.doi.org/10.1016/j.placenta.2006.05.006.
22. Warner JA, Zwezdaryk KJ, Day B, Sullivan DE, Pridjian G, Morris CA. 2012. Human cytomegalovirus infection inhibits CXCL12-mediated migration and invasion of human extravillous cytotrophoblasts. Virol J 9:255. http://dx.doi.org/10.1186/1743-422X-9-255.
23. Tabata T, Petitt M, Zydek M, Fang-Hoover J, Larocque N, Tsuge M, Gormley M, Kauvar LM, Pereira L. 2015. Human cytomegalovirus infection interferes with the maintenance and differentiation of trophoblast progenitor cells of the human placenta. J Virol 89:5134-5147. http://dx.doi.org/10.1128/JVI.03674-14.
24. Hamilton ST, Scott GM, Naing Z, Rawlinson WD. 2013. Human cytomegalovirus directly modulates expression of chemokine CCL2 (MCP-1) during viral replication. J Gen Virol 94:2495-2503. http://dx.doi.org/10.1099/vir.0.052878-0.
25. Yamamoto-Tabata T, McDonagh S, Chang HT, Fisher S, Pereira L. 2004. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol 78:2831-2840. http://dx.doi.org/10.1128/JVI.78.6.2831-2840.2004.
26. Fisher S, Genbacev O, Maidji E, Pereira L. 2000. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 74:6808-6820. http://dx.doi.org/10.1128/JVI.74.15.6808-6820.2000.
27. Chou D, Ma Y, Zhang J, McGrath C, Parry S. 2006. Cytomegalovirus infection of trophoblast cells elicits an inflammatory response: a possible mechanism of placental dysfunction. Am J Obstet Gynecol 194:535-541. http://dx.doi.org/10.1016/j.ajog.2005.07.073.
28. Kovács IJ, Hegedus K, Pal A, Pusztai R. 2007. Production of proinflammatory cytokines by syncytiotrophoblasts infected with human cytomegalovirus isolates. Placenta 28:620-623. http://dx.doi.org/10.1016/j.placenta.2006.09.008.
29. Schleiss MR, Aronow BJ, Handwerger S. 2007. Cytomegalovirus infection of human syncytiotrophoblast cells strongly interferes with expression of genes involved in placental differentiation and tissue integrity. Pediatr Res 61:565-571. http://dx.doi.org/10.1203/pdr.0b013e318045be6d.
30. Tao L, Suhua C, Juanjuan C, Zongzhi Y, Juan X, Dandan Z. 2011. In vitro study on human cytomegalovirus affecting early pregnancy villous EVT's invasion function. Virol J 8:114. http://dx.doi.org/10.1186/1743-422X-8-114.
31. Tabata T, Petitt M, Fang-Hoover J, Rivera J, Nozawa N, Shiboski S, Inoue N, Pereira L. 2012. Cytomegalovirus impairs cytotrophoblastinduced lymphangiogenesis and vascular remodeling in an in vivo human placentation model. Am J Pathol 181:1540-1559. http://dx.doi.org/10.1016/j.ajpath.2012.08.003.
32. LaMarca HL, Nelson AB, Scandurro AB, Whitley GS, Morris CA. 2006. Human cytomegalovirus-induced inhibition of cytotrophoblast invasion in a first trimester extravillous cytotrophoblast cell line. Placenta 27:137-147. http://dx.doi.org/10.1016/j.placenta.2005.03.003.
33. Knöfler M. 2010. Critical growth factors and signalling pathways controlvan ling human trophoblast invasion. Int J Dev Biol 54:269-280. http://dx.doi.org/10.1387/ijdb.082769mk.
34. Wu D, Luo S, Wang Y, Zhuang L, Chen Y, Peng C. 2001. Smads in human trophoblast cells: expression, regulation and role in TGF-betainduced transcriptional activity. Mol Cell Endocrinol 175:111-121. http://dx.doi.org/10.1016/S0303-7207(01)00397-5.
35. Knöfler M, Pollheimer J. 2013. Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling. Front Genet 4:190.
36. Bao SH, Shuai W, Tong J, Wang L, Chen P, Duan T. 2013. Increased Dickkopf-1 expression in patients with unexplained recurrent spontaneous miscarriage. Clin Exp Immunol 172:437-443. http://dx.doi.org/10.1111/cei.12066.
37. Zhang Z, Zhang L, Jia L, Wang P, Gao Y. 2013. Association of Wnt2 and sFRP4 expression in the third trimester placenta in women with severe preeclampsia. Reprod Sci 20:981-989. http://dx.doi.org/10.1177/1933719112472740.
38. Chien AJ, Conrad WH, Moon RT. 2009. A Wnt survival guide: from flies to human disease. J Invest Dermatol 129:1614-1627. http://dx.doi.org/10.1038/jid.2008.445.
39. Angelova M, Zwezdaryk K, Ferris M, Shan B, Morris CA, Sullivan DE. 2012. Human cytomegalovirus infection dysregulates the canonical Wnt/beta-catenin signaling pathway. PLoS Pathog 8:e1002959. http://dx.doi.org/10.1371/journal.ppat.1002959.
40. O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, French AD, Dissanayake SK, Indig FE, Bernier M, Taub DD, Hewitt SM, Weeraratna AT. 2010. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 29:34-44. http://dx.doi.org/10.1038/onc.2009.305.
41. Kremenevskaja N, von Wasielewski R, Rao AS, Schofl C, Andersson T, Brabant G. 2005. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24:2144-2154. http://dx.doi.org/10.1038/sj.onc.1208370.
42. Dejmek J, Dejmek A, Safholm A, Sjolander A, Andersson T. 2005. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 65:9142-9146. http://dx.doi.org/10.1158/0008-5472.CAN-05-1710.
43. Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Arroyave R, Vijayakumar S, Economides AN, Aaronson SA. 2010. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24:2517-2530. http://dx.doi.org/10.1101/gad.1957710.
44. Kani S, Oishi I, Yamamoto H, Yoda A, Suzuki H, Nomachi A, Iozumi K, Nishita M, Kikuchi A, Takumi T, Minami Y. 2004. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. J Biol Chem 279:50102-50109. http://dx.doi.org/10.1074/jbc.M409039200.
45. Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, Koshida I, Suzuki K, Yamada G, Schwabe GC, Mundlos S, Shibuya H, Takada S, Minami Y. 2003. The receptor tyrosine kinase Ror2 is involved in noncanonical Wnt5a/JNK signalling pathway. Genes Cells 8:645-654. http://dx.doi.org/10.1046/j.1365-2443.2003.00662.x.
46. Yamamoto H, Yoo SK, Nishita M, Kikuchi A, Minami Y. 2007. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Genes Cells 12:1215-1223. http://dx.doi.org/10.1111/j.1365-2443.2007.01128.x.
47. Ford CE, Qian Ma SS, Quadir A, Ward RL. 2013. The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis. Int J Cancer 133:779-787. http://dx.doi.org/10.1002/ijc.27984.
48. Shiverick KT, King A, Frank H, Whitley GS, Cartwright JE, Schneider H. 2001. Cell culture models of human trophoblast II: trophoblast cell lines-a workshop report. Placenta 22(Suppl A):S104-S106.
49. LaMarca HL, Sainz B, Jr, Morris CA. 2004. Permissive human cytomegalovirus infection of a first trimester extravillous cytotrophoblast cell line. Virol J 1:8. http://dx.doi.org/10.1186/1743-422X-1-8.
50. Doyon P, van Zuylen WJ, Servant MJ. 2013. Role of IkappaB kinase-beta in the growth-promoting effects of angiotensin II in vitro and in vivo. Arterioscler Thromb Vasc Biol 33:2850-2857. http://dx.doi.org/10.1161/ATVBAHA.113.302487.
51. van Zuylen WJ, Garceau V, Idris A, Schroder K, Irvine KM, Lattin JE, Ovchinnikov DA, Perkins AC, Cook AD, Hamilton JA, Hertzog PJ, Stacey KJ, Kellie S, Hume DA, Sweet MJ. 2011. Macrophage activation and differentiation signals regulate schlafen-4 gene expression: evidence for Schlafen-4 as a modulator of myelopoiesis. PLoS One 6:e15723. http://dx.doi.org/10.1371/journal.pone.0015723.
52. Pollheimer J, Loregger T, Sonderegger S, Saleh L, Bauer S, Bilban M, Czerwenka K, Husslein P, Knofler M. 2006. Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol 168:1134-1147. http://dx.doi.org/10.2353/ajpath.2006.050686.
53. Sonderegger S, Haslinger P, Sabri A, Leisser C, Otten JV, Fiala C, Knofler M. 2010. Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology 151:211-220. http://dx.doi.org/10.1210/en.2009-0557.
54. Ford CE, Punnia-Moorthy G, Henry CE, Llamosas E, Nixdorf S, Olivier J, Caduff R, Ward RL, Heinzelmann-Schwarz V. 2014. The noncanonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Gynecol Oncol 134:338-345. http://dx.doi.org/10.1016/j.ygyno.2014.06.004.
55. Hirsch AJ, Shenk T. 1999. Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene. J Virol 73:404-410.
56. Sonderegger S, Husslein H, Leisser C, Knofler M. 2007. Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 28(Suppl A):S97-S102.